Intellectual Property India Publishes Patent Application for 'Activin Receptor Type Iib Variants And Uses Thereof' Filed by 35Pharma Inc.

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517069798 A) filed by 35Pharma Inc., Montreal, on July 22, for 'activin receptor type iib variants and uses thereof.'

Inventor(s) include Tremblay, Gilles; Ganesh, Vannakambadi K.; O'Connor-Mccourt, Maureen D.; and Schang, Gauthier.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "There are provided polypeptides that include an Activin receptor type IIB (ActRIIB) ectodomain (ECD) variant. In some embodiments, a polypeptide of the disclosure includes an ActRIIB-ECD variant fused to an Fc domain moiety. The disclosure also provides pharmaceuti...